Aurobindo Pharma gained 1.5 percent intraday Tuesday to hit fresh 52-week high of Rs 885 on getting US health regulator approval for antiulcer drug
Lupin gained more than 1 percent intraday on getting nod from USFDA to market generic Femhrt tablets in the US.
Lupin gained more than 1 percent intraday on getting nod from USFDA to market generic Femhrt tablets in the US.
No comments:
Post a Comment